MSDC-0602K, a PPAR-gamma sparing modulator of the mitochondrial pyruvate carrier, improves NASH outcome in a diet-induced animal model of non-alcoholic steatohepatitis

pioglitazone - generics

MSDC-0602K - Cirius Therap

Avandia (rosiglitazone) - GSK

https://program.m-anage.com/ilc2019/en-GB/PublicProgram/NavigateToProgramdetails/63253?pProgramGrade=Scientific&pHideLogin=False&pHidePersonal=True

Rebecca Caffrey1; Jonathon Marioneaux1; Jerry Colca2; Pierre Bedossa3; Arun Sanyal41Sanyal Biotechnology, Norfolk, United States; 2Cirius Therapeutics, Kalamazoo, MI, United States; 3LiverPat, Paris, France; 4Virginia Commonwealth University, Richmond, United StatesEmail: [email protected]

Apr 16, 2019